Personalis (PSNL)
(Real Time Quote from BATS)
$1.34 USD
-0.02 (-1.47%)
Updated Jun 14, 2024 01:20 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 39% (97 out of 249)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.42 | 9.99 |
Current Quarter Estimate | -0.34 | 1.25 | 57.00 |
Year Ago Quarter Estimate | -0.50 | -4.28 | 52.54 |
Next Quarter Estimate | -0.34 | 1.37 | 61.00 |
Next Year Estimate | -1.07 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 41.47 | 17.10 | 15.67 |
Next Year | 15.75 | 16.10 | 9.31 |
Last 5 Years | NA | 0.10 | 8.10 |
Next 5 Years | NA | 14.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 1.64 |
Price/Book (MRQ) | 0.59 | 1.46 |
Price/Cash Flow (MRFY) | NA | 10.41 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -124.90% | -55.42% |
Return on Equity (TTM) | -58.31% | -57.25% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.